Sintaho Pharmaceutical Ltd was established in the year of 2016 and headquartered in Chongqing China, with a grand vison of being the most trusted partner to pharmaceutical companies worldwide. We have a clear focus on developing and manufacturing highly potent and cytotoxic Active Pharmaceutical Ingredients (APIs) and CDMO services.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Paliperidone Palmitate</strong> is a long-acting injectable antipsychotic, chemically defined as the palmitate ester of paliperidone. Its synthesis involves esterification to extend half-life for sustained release. <strong>Molecular Formula</strong>: C29H40FN3O6; <strong>CAS No.</strong>: 871568-95-1.</p>
<h3>Application</h3>
<ul>
<li>Treatment of schizophrenia in adult patients via intramuscular injection.</li>
<li>Management of schizoaffective disorder with maintenance therapy protocols.</li>
<li>Industrial API supply for formulation into depot injections by pharmaceutical manufacturers.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in patients with hypersensitivity to risperidone or paliperidone. Store under controlled room temperature conditions (20°C–25°C) and protect from light to maintain stability during logistics.</p>